News & Events / News / 2009
text size: Default style Switch styles (larger text) Switch styles (largest text)
News Archive: 2009

November 29, 2009
Alzheimers: Experimental drug offers new hope for patients

The fluid flowing into Alan Romatowski's left arm for an hour could be a magical solution stopping his Alzheimer's disease in its tracks or a drug that fails to live up to its promise or even a placebo without any chance of helping him...

Click here to read full article »

July 11-16,2009
News from ICAD 2009 (International Conference on Alzheimer's Disease)

Leading scientists from around the world shared their latest Alzheimer research at the International Conference on Alzherimer's Disease (ICAD). ICAD 2009 drew nearly 3,800 international attendees to Vienna. Breaking research and new technology captured global media attention as the world's leading scientists explored innovative ways to unlock the mysteries of Alzheimer's.

Click here to read articles from the conference »

Friday, May 10-12, 2009
HBO's The Alzheimer's Project

HBO’s The Alzheimer’s Project is four-part documentary series that airs May 10 – 12, 2009. These films investigate groundbreaking Alzheimer discoveries made by the country’s leading researchers and the effects this disabling and fatal disease has on those with Alzheimer’s disease and their families. ADRC researchers Dr. William Klunk and Dr. Chester Mathis are featured in the scientific film as well as a family that is involved in the ADRC PiB research. To learn more about The Alzheimer’s Project visit

Wednesday, March 25, 2009
ADRC Researchers are awarded the 2009 Ronald and Nancy Reagan Research Institute Award

William E. Klunk. M.D., Ph.D., and Chester A. Mathis, Ph.D. have received the 2009 Ronald and Nancy Reagan Research Institute Award for outstanding contributions to research, care, and advocacy on behalf of Alzheimer’s patients and their caregivers. The Alzheimer’s Association—the largest voluntary health organization dedicated to finding prevention methods, treatments, and an eventual cure for Alzheimer’s—presented the award to Klunk and Mathis at an association gala in Washington, D.C., on March 25.

Klunk and Mathis have developed experimental noninvasive methods of detecting and creating images of amyloid-beta proteins (plaques that form in the brain tissue of Alzheimer’s sufferers) using dyes to make the plaques visible through the use of medical imaging equipment. The ability to see amyloid deposits in living patients will enable researchers to directly measure the effects of anti-amyloid therapies now being developed.

Klunk is a professor of psychiatry in Pitt’s medical school, co director the University of Pittsburgh Alzheimer Disease Research Center, and director of the Laboratory of Molecular Neuropharmacology at Western Psychiatric Institute and Clinic. Mathis is director of the UPMC PET Center and Professor and Vice Chair of Research in the Department of Radiology. The dietary supplement Ginkgo biloba was found to be ineffective in reducing the development of dementia and Alzheimer's disease in older people, according to a study published in the "Journal of the American Medical Association"{1}. Researchers led by Stephen T. DeKosky, M.D., formerly of the University of Pittsburgh, vice president and dean of the School of Medicine at the University of Virginia in Charlottesville, conducted the trial known as the Ginkgo Evaluation of Memory (GEM) study at four clinical sites over the course of 8 years. GEM is the largest clinical trial ever to evaluate ginkgo's effect on the occurrence of dementia. more »